Literature DB >> 15372596

Differences in age at onset and familial aggregation between clinical types of idiopathic Parkinson's disease.

Alexei Korchounov1, Hayo I Schipper, Irina S Preobrazhenskaya, Kirn R Kessler, Nikolay N Yakhno.   

Abstract

Idiopathic Parkinson's disease (PD) can be subdivided by its patterns of motor symptoms into tremor-dominant (TDT), akinetic-rigid (ART), and mixed type (MT). Our objective was to determine whether age at onset and family history are different in these three types. In total, 366 patients with PD were assigned in a standardized approach to one of the three subtypes. Age at onset and family history were obtained in all patients and all presumably affected family members were examined. Mean ages at disease onset were similar in all three groups, but distribution of age at onset was markedly different: monophasic in TDT with a peak around 60 years, biphasic in ART with two peaks, one in the middle of the sixth decade (earlier onset, ART-EO), another during the first half of the seventh decade (later onset, ART-LO), and increasing with age only in MT patients A positive family history was significantly associated only with TDT (odds ratio = 5.7) and ART-EO (odds ratio = 7.8), but not with MT or ART-LO patients. Segregation analysis suggested an autosomal recessive mode of transmission in ART-EO and an autosomal dominant mode of transmission in TDT.

Entities:  

Mesh:

Year:  2004        PMID: 15372596     DOI: 10.1002/mds.20061

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  12 in total

1.  Coordination between upper- and lower-limb movements is different during overground and treadmill walking.

Authors:  Ilaria Carpinella; Paolo Crenna; Marco Rabuffetti; Maurizio Ferrarin
Journal:  Eur J Appl Physiol       Date:  2009-09-16       Impact factor: 3.078

2.  Substantia nigra echogenicity in Parkinson's disease: relation to serum iron and C-reactive protein.

Authors:  Uwe Walter; Rike Witt; Alexander Wolters; Matthias Wittstock; Reiner Benecke
Journal:  J Neural Transm (Vienna)       Date:  2011-05-31       Impact factor: 3.575

3.  Differences in striatal dopamine transporter density between tremor dominant and non-tremor Parkinson's disease.

Authors:  Valtteri Kaasinen; Maija Kinos; Juho Joutsa; Marko Seppänen; Tommi Noponen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05-28       Impact factor: 9.236

4.  Clinical characteristics in early Parkinson's disease in a central California population-based study.

Authors:  Gail A Kang; Jeff M Bronstein; Donna L Masterman; Matthew Redelings; Jarrod A Crum; Beate Ritz
Journal:  Mov Disord       Date:  2005-09       Impact factor: 10.338

5.  Striatal FP-CIT uptake differs in the subtypes of early Parkinson's disease.

Authors:  J Spiegel; D Hellwig; S Samnick; W Jost; M-O Möllers; K Fassbender; C-M Kirsch; U Dillmann
Journal:  J Neural Transm (Vienna)       Date:  2006-05-24       Impact factor: 3.575

Review 6.  Cognition, language, and clinical pathological features of non-Alzheimer's dementias: an overview.

Authors:  Jamie Reilly; Amy D Rodriguez; Martine Lamy; Jean Neils-Strunjas
Journal:  J Commun Disord       Date:  2010-05-06       Impact factor: 2.288

7.  Deep brain stimulation for Parkinson's disease and other movement disorders: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2005-03-01

Review 8.  Therapy of Parkinson's Disease Subtypes.

Authors:  Connie Marras; K Ray Chaudhuri; Nataliya Titova; Tiago A Mestre
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

9.  A whole-brain analysis in de novo Parkinson disease.

Authors:  C Tessa; M Giannelli; R Della Nave; C Lucetti; C Berti; A Ginestroni; U Bonuccelli; M Mascalchi
Journal:  AJNR Am J Neuroradiol       Date:  2008-01-09       Impact factor: 3.825

10.  Executive function network's white matter alterations relate to Parkinson's disease motor phenotype.

Authors:  Qinglu Yang; Shruti Nanivadekar; Paul A Taylor; Zulin Dou; Codrin I Lungu; Silvina G Horovitz
Journal:  Neurosci Lett       Date:  2020-11-05       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.